Tandem Diabetes Care (TNDM) Equity Income (2024 - 2026)

Tandem Diabetes Care (TNDM) has reported Equity Income for 3 consecutive years, with -$5.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Equity Income fell 65.91% year-over-year to -$5.6 million; the trailing twelve-month figure through Jun 2026 stood at -$16.8 million (down 86.07% YoY), and the FY2025 full-year result was -$14.2 million, down 576.19% from the prior year.
• Equity Income eased to -$5.6 million in Q2 2026 per TNDM's latest filing, from -$3.9 million in the prior quarter.
• Across five years, Equity Income topped out at -$2.1 million in Q4 2024 and bottomed at -$5.6 million in Q2 2026.
• Historically, Equity Income has averaged -$3.7 million across 3 years, with a median of -$3.5 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Equity Income plunged 117.1% in 2025, then retreated 10.11% in 2026.
• Over 3 years, Equity Income stood at -$2.1 million in 2024, then slumped by 117.1% to -$4.6 million in 2025, then decreased by 23.73% to -$5.6 million in 2026.
• According to Business Quant data, Equity Income over the past three periods registered -$5.6 million, -$3.9 million, and -$4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.